Tariffs On Medicines
-
{
- All
- News
- Videos
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
The bigger picture threatens a move away from established production hubs like India.
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
US Tariff Cuts May Boost India's Traditional Medicine And Nutrition Sectors: Experts
India's traditional medicine and nutrition supplement sectors are set to gain from the United States tariff reduction under the India-US Interim Trade Deal.
-
EU Cites Trade Deal Immunity As Trump Hits Pharma With 100% Tariff
US President Donald Trump's announcement of steep new tariffs on medicines and other goods drew pushback from some allies on Friday, with the EU claiming immunity for its pharmaceutical industry under an earlier trade deal.
-
Trump's "Medicine" Reply To Tariff Question As Black Monday Fear Looms
Asian stock markets opened in a bloodbath on Monday as US futures pointed to significant losses on Wall Street over US President Donald Trump's punishing tariffs, even as countries sought compromise with the defiant president.
-
How Trump's Tariffs On India Will Backfire On The US Healthcare System
The US relies heavily on Indian generic medicines, with nearly half of all generic drugs consumed in the US originating from India. This has resulted in significant savings for the US healthcare system.
-
China's Plan To Import Indian Medicines Receives Cold Response From Pharma Firms
China's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the Indian pharmaceutical firms as exports to China are possible only after lengthy field trials and approvals, which could take years, an official at an Indian firm has said.
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
The bigger picture threatens a move away from established production hubs like India.
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
US Tariff Cuts May Boost India's Traditional Medicine And Nutrition Sectors: Experts
India's traditional medicine and nutrition supplement sectors are set to gain from the United States tariff reduction under the India-US Interim Trade Deal.
-
EU Cites Trade Deal Immunity As Trump Hits Pharma With 100% Tariff
US President Donald Trump's announcement of steep new tariffs on medicines and other goods drew pushback from some allies on Friday, with the EU claiming immunity for its pharmaceutical industry under an earlier trade deal.
-
Trump's "Medicine" Reply To Tariff Question As Black Monday Fear Looms
Asian stock markets opened in a bloodbath on Monday as US futures pointed to significant losses on Wall Street over US President Donald Trump's punishing tariffs, even as countries sought compromise with the defiant president.
-
How Trump's Tariffs On India Will Backfire On The US Healthcare System
The US relies heavily on Indian generic medicines, with nearly half of all generic drugs consumed in the US originating from India. This has resulted in significant savings for the US healthcare system.
-
China's Plan To Import Indian Medicines Receives Cold Response From Pharma Firms
China's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the Indian pharmaceutical firms as exports to China are possible only after lengthy field trials and approvals, which could take years, an official at an Indian firm has said.
